This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A third view: discussing the potential of low dose naltrexone for treating Post-COVID fatigue syndrome

Ticker(s): IBB

Who's the expert?

Institution: Optum Care

  • Board certified in Internal Medicine
  • practicing as a hospitalist for Optum Care at several community hospitals in Southern California
  • has seen roughly 100 COVID patients over the year and is comfortable discussing long COVID

Interview Goal
see title.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.